Crossmark

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

Crossref DOI link: https://doi.org/10.1186/s12879-019-3871-0

Published Online: 2019-03-12

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takou, Desire

Fokam, Joseph https://orcid.org/0000-0002-1501-2763
Teto, Georges

Santoro, Maria-Mercedes

Ceccherini-Silberstein, Francesca

Nanfack, Aubin Joseph

Sosso, Samuel Martin

Dambaya, Béatrice

Salpini, Romina

Billong, Serge Clotaire

Gori, Caterina

Fokunang, Charles Ntungwen

Cappelli, Giulia

Colizzi, Vittorio

Perno, Carlo-Federico

Ndjolo, Alexis
Funding

Funding for this research was provided by:

Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management (PTA 2016)
License Information

Text and Data Mining valid from 2019-03-12
More Information

Article History

Received: 24 August 2018

Accepted: 4 March 2019

First Online: 12 March 2019

Ethics approval and consent to participate

: Ethical clearance was obtained from the Ethics Review and Consultancy Committee of the Cameroon Bioethics Initiative (Reference number: CBI/2013/0139/ERCC/CAMBIN), and written informed consent was provided. For those participants under 16 years of age, a written proxy-informed consent was provided to the study coordinators by the respective parent(s) or legal guardian(s), followed by an assent provided by the corresponding participant. Data were de-identified for purpose of confidentiality and privacy in data management.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below